ID   HeLa CD4+ Clone1022
AC   CVCL_U339
SY   HeLa CD4+Clone1022; Clone 1022
DR   CLO; CLO_0050933
DR   BioSample; SAMN03471970
DR   HIVReagentProgram; ARP-1109
DR   RCB; RCB2355
DR   Wikidata; Q54882525
RX   PubMed=1984477;
CC   Population: African American.
CC   Doubling time: ~38 hours (HIVReagentProgram=ARP-1109).
CC   Transfected with: HGNC; 1678; CD4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 15
RX   PubMed=1984477; DOI=10.1093/infdis/163.1.64;
RA   Chesebro B.W., Wehrly K., Metcalf J., Griffin D.E.;
RT   "Use of a new CD4-positive HeLa cell clone for direct quantitation of
RT   infectious human immunodeficiency virus from blood cells of AIDS
RT   patients.";
RL   J. Infect. Dis. 163:64-70(1991).